Glucagon-like Peptide I Amide Fragment 7-36

• Description:

  Glucagon-like Peptide I Amide Fragment 7-36 _x000D_ Catalog number: B2014034_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 0.1 mg_x000D_ Molecular Weight or Concentration: 3297.6 g/mol_x000D_ Supplied as: Powder_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: −20°C_x000D_ Keywords: Glucagon-Like Peptide I Amide Fragment 7-36 human_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Laurindo LF, Barbalho SM, Guiguer EL, da Silva Soares de Souza M, de Souza GA, Fidalgo TM, Arajo AC, de Souza Gonzaga HF, de Bortoli Teixeira D, de Oliveira Silva Ullmann T, Sloan KP, Sloan LA. GLP-1a: Going beyond Traditional Use Int J Mol Sci. 2022 Jan 10;23(2):739._x000D_ 2: Blzquez E, Alvarez E, Navarro M, Roncero I, Rodr_guez-Fonseca F, Chowen JA, Zueco JA. Glucagon-like peptide-1 (7-36) amide as a novel neuropeptide Mol Neurobiol. 1998 Oct;18(2):157-73._x000D_ 3: Ban K, Kim KH, Cho CK, Sauv M, Diamandis EP, Backx PH, Drucker DJ, Husain M. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor Endocrinology. 2010 Apr;151(4):1520-31._x000D_ 4: Vara E, Arias-D_az J, Garcia C, Balibrea JL, Blzquez E. Glucagon-like peptide-1(7-36) amide stimulates surfactant secretion in human type II pneumocytes Am J Respir Crit Care Med. 2001 Mar;163(4):840-6._x000D_ 5: Mrida E, Delgado E, Molina LM, Villanueva-Peacarrillo ML, Valverde I. Presence of glucagon and glucagon-like peptide-1-(7-36)amide receptors in solubilized membranes of human adipose tissue J Clin Endocrinol Metab. 1993 Dec;77(6):1654-7._x000D_ 6: O'Halloran DJ, Nikou GC, Kreymann B, Ghatei MA, Bloom SR. Glucagon-like peptide-1 (7-36)-NH2: a physiological inhibitor of gastric acid secretion in man J Endocrinol. 1990 Jul;126(1):169-73._x000D_ 7: Gutniak M, Orskov C, Holst JJ, Ahrn B, Efendic S. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus N Engl J Med. 1992 May 14;326(20):1316-22._x000D_ 8: Gromada J, Bokvist K, Ding WG, Holst JJ, Nielsen JH, Rorsman P. Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling Diabetes. 1998 Jan;47(1):57-65._x000D_ 9: Nauck MA, Wollschl_ger D, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Willms B. Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM Diabetologia. 1996 Dec;39(12):1546-53._x000D_ 10: van Dijk G, Thiele TE. Glucagon-like peptide-1 (7-36) amide: a central regulator of satiety and interoceptive stress Neuropeptides. 1999 Oct;33(5):406-14. _x000D_ _x000D_ Products Related to Glucagon-like Peptide I Amide Fragment 7-36 can be found at Peptides

• Short Description:

  Catalog Number: B2014034 (0.1 mg)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5